Name | Number of supported studies | Average coverage | |
---|---|---|---|
hematopoietic precursor cell | 4 studies | 24% ± 9% | |
epithelial cell | 4 studies | 22% ± 7% | |
plasmablast | 3 studies | 21% ± 6% | |
abnormal cell | 3 studies | 17% ± 1% | |
erythroblast | 3 studies | 49% ± 25% | |
granulocyte monocyte progenitor cell | 3 studies | 20% ± 3% | |
erythrocyte | 3 studies | 33% ± 13% | |
transit amplifying cell | 3 studies | 38% ± 8% | |
natural killer cell | 3 studies | 33% ± 6% | |
effector CD8-positive, alpha-beta T cell | 3 studies | 27% ± 8% | |
CD8-positive, alpha-beta T cell | 3 studies | 25% ± 3% |
Insufficient scRNA-seq data for expression of MCM4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 1363.06 | 457 / 459 | 99% | 79.68 | 1104 / 1118 |
bladder | 100% | 1334.48 | 21 / 21 | 98% | 74.72 | 492 / 504 |
skin | 100% | 5017.55 | 1809 / 1809 | 97% | 69.00 | 460 / 472 |
uterus | 95% | 854.86 | 162 / 170 | 99% | 114.99 | 455 / 459 |
intestine | 96% | 1473.26 | 923 / 966 | 97% | 69.77 | 513 / 527 |
ovary | 94% | 986.56 | 169 / 180 | 98% | 49.37 | 423 / 430 |
brain | 96% | 1474.32 | 2524 / 2642 | 96% | 40.69 | 679 / 705 |
esophagus | 91% | 1908.18 | 1319 / 1445 | 100% | 79.39 | 183 / 183 |
stomach | 90% | 1041.86 | 322 / 359 | 98% | 68.01 | 280 / 286 |
lung | 84% | 926.81 | 486 / 578 | 95% | 63.53 | 1102 / 1155 |
thymus | 93% | 732.81 | 607 / 653 | 81% | 25.16 | 491 / 605 |
adrenal gland | 100% | 1714.86 | 258 / 258 | 71% | 21.07 | 164 / 230 |
pancreas | 82% | 604.34 | 270 / 328 | 80% | 25.94 | 142 / 178 |
kidney | 96% | 1093.61 | 85 / 89 | 51% | 11.84 | 458 / 901 |
prostate | 92% | 871.60 | 226 / 245 | 46% | 10.28 | 233 / 502 |
liver | 57% | 534.60 | 128 / 226 | 58% | 19.79 | 236 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 74.73 | 29 / 29 |
tonsil | 0% | 0 | 0 / 0 | 100% | 130.87 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.03 | 1 / 1 |
spleen | 98% | 1667.92 | 237 / 241 | 0% | 0 | 0 / 0 |
muscle | 98% | 1101.12 | 788 / 803 | 0% | 0 | 0 / 0 |
adipose | 98% | 995.48 | 1179 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 89% | 686.61 | 1187 / 1335 | 0% | 0 | 0 / 0 |
heart | 86% | 1007.01 | 742 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 69% | 22.78 | 55 / 80 |
peripheral blood | 51% | 3543.36 | 471 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0000727 | Biological process | double-strand break repair via break-induced replication |
GO_0006271 | Biological process | DNA strand elongation involved in DNA replication |
GO_1902975 | Biological process | mitotic DNA replication initiation |
GO_0006268 | Biological process | DNA unwinding involved in DNA replication |
GO_0006260 | Biological process | DNA replication |
GO_0030174 | Biological process | regulation of DNA-templated DNA replication initiation |
GO_0042555 | Cellular component | MCM complex |
GO_0071162 | Cellular component | CMG complex |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016020 | Cellular component | membrane |
GO_0005634 | Cellular component | nucleus |
GO_0003678 | Molecular function | DNA helicase activity |
GO_0005515 | Molecular function | protein binding |
GO_0003697 | Molecular function | single-stranded DNA binding |
GO_0017116 | Molecular function | single-stranded DNA helicase activity |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | MCM4 |
Protein name | Minichromosome maintenance complex component 4 DNA replication licensing factor MCM4 (EC 3.6.4.12) DNA helicase (EC 3.6.4.12) DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21) Minichromosome maintenance protein 4 (EC 3.6.1.15) |
Synonyms | CDC21 |
Description | FUNCTION: Acts as a component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built . The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity . . FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. . FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. . FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. . FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. . FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. . FUNCTION: Acts as component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity. . |
Accessions | E5RHP5 A0A3B3IRR8 ENST00000697122.1 ENST00000649838.1 ENST00000647877.1 ENST00000649973.1 A0A3B3IS88 A4FS09 ENST00000648407.1 A0A8V8TKP2 ENST00000524086.5 ENST00000648554.1 A0A3B3IT92 P33991 E5RG53 ENST00000649919.1 A0A3B3IS57 ENST00000262105.6 A0A3B3IU45 A0A3B3ISC1 E5RFR3 ENST00000520637.2 ENST00000518382.1 E5RG31 ENST00000518221.5 ENST00000648519.1 ENST00000650216.1 A0A3B3ITP6 |